Cargando…
1167. Dialysis-Related Bloodstream Infections: A Pre- and Post-ClearGuard HD Cap Conception Study
BACKGROUND: 25% of patients on hemodialysis receive therapy via a tunneled dialysis catheter (TDC). Bacteremia is one of the most feared complications with an all-cause mortality rate of 12–25%, Medicare spending costs amounting nearly $600 million annually and average hospital length of stay of 12...
Autores principales: | Li, William, Otto, Caitlin, Nakeshbandi, Mohamed, Augenbraun, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809387/ http://dx.doi.org/10.1093/ofid/ofz360.1030 |
Ejemplares similares
-
Clinical and biochemical effects of a combination botanical product (ClearGuard™) for allergy: a pilot randomized double-blind placebo-controlled trial
por: Corren, Jonathan, et al.
Publicado: (2008) -
The Plague of 1167
Publicado: (1895) -
1108. Impact of Implementing a Urine Culture Order Set on Antibiotic Utilization and Rates of Catheter-Associated Urinary Tract Infections in an Urban Academic Medical Center
por: Alnafoosi, Zainab, et al.
Publicado: (2019) -
1167. Got Micafungin? The Incidence of Fungemia in Patients with Septic Shock
por: Piche, Mackenzie, et al.
Publicado: (2020) -
A catalogue of 1,167 genomes from the human gut archaeome
por: Chibani, Cynthia Maria, et al.
Publicado: (2021)